Esra Zeynelgil

8PUBLICATIONS
36CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 14, 2026
Impact of Prior mRNA COVID-19 Vaccination on PFS2 in NSCLC Patients Receiving Second-Line Immune Checkpoint Inhibitors: A Real-World Analysis.

Selahattin Çelik, Engin Eren Kavak, Esra Zeynelgil

|Jan 27, 2026
Prognostic Significance of Lung Immune Prognostic Index at Diagnosis in Stage III Non-Small Cell Lung Cancer.

Tülay Eren, Engin Eren Kavak, İsmail Dili

|Jan 10, 2026
Prognostic Value of STAS, Lymph Node Metastasis, and VPI in NSCLC ≤ 4 cm Treated with Lobectomy.

Esra Zeynelgil, Abdülkadir Koçanoğlu, Ata Türker Arıkök

|Dec 16, 2025
BMI and PNI as predictors of treatment completion and survival in locally advanced HNSCC receiving sequential chemoradiotherapy.

Esra Zeynelgil, Engin Eren Kavak, İsmail Dilli

|Nov 10, 2025
Do Inflammatory and Nutritional Markers Predict Prognosis in Metastatic Non-Small Cell Lung Cancer Patients Receiving Nivolumab.

Esra Zeynelgil, Dilek Çağlayan, Selahattin Çelik

|Jun 27, 2025
Dynamic Alteration of HALP Score as a Predictor in Patients with Receiving Immunotherapy for Advanced Non-Small Cell Lung Cancer.

Abdülkadir Koçanoğlu, Serdar Karakaya, Esra Zeynelgil

Pageof 2

Frequent Collaborators

4 joint publications

Engin Eren Kavak

3 joint publications

Tulay Eren

2 joint publications

İsmail Dilli

2 joint publications

Goksen Inanc Imamoglu